Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study (Q46357275)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study |
scientific article |
Statements
1 reference
Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study (English)
1 reference
Thomas J Moretto
1 reference
Denái R Milton
1 reference
Terry D Ridge
1 reference
Leigh A Macconell
1 reference
Ted Okerson
1 reference
Anne M Wolka
1 reference
Robert G Brodows
1 reference
1 August 2008
1 reference
1 reference
30
1 reference
8
1 reference
1448-1460
1 reference